Wilzin Alternatives Compared
| Wilzin (zinc acetate) | Penicillamine | Cuprimine (penicillamine) |
|
|---|
| Wilzin (zinc acetate) | Penicillamine | Cuprimine (penicillamine) |
|
|||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Prescription only
Prescribed for Wilson's Disease. Wilzin may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Wilson's Disease, Cystinuria, Rheumatoid Arthritis. Penicillamine may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for Wilson's Disease, Cystinuria, Rheumatoid Arthritis. Cuprimine may also be used for purposes not listed in this medication guide. |
Related suggestions Wilson's Disease
|
|||||||||||||||
| More about (zinc acetate) | More about Penicillamine | More about Cuprimine (penicillamine) | ||||||||||||||||
| Ratings & Reviews | ||||||||||||||||||
|
Be the first to share your experience with this drug. |
Penicillamine has an average rating of 9.0 out of 10 from a total of 2 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
Cuprimine has an average rating of 10.0 out of 10 from a total of 1 ratings on Drugs.com. 100% of reviewers reported a positive effect, while 0% reported a negative effect. |
||||||||||||||||
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||||||||||||||||||
|
View all Wilzin side effects |
View all Penicillamine side effects |
View all Cuprimine side effects |
||||||||||||||||
| Drug Class | ||||||||||||||||||
| Generic Availability | ||||||||||||||||||
|
N/A |
Lower cost generic |
|||||||||||||||||
| Pricing and Coupons * Prices are without insurance | ||||||||||||||||||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
View all Penicillamine prices |
View all Cuprimine prices |
||||||||||||||||
| Dosage Forms | ||||||||||||||||||
|
N/A |
|
|
||||||||||||||||
| Brand Names | ||||||||||||||||||
| Other zinc acetate brands include: Galzin | Cuprimine, D-Penamine, Depen, Depen Titratabs | Other penicillamine brands include: D-Penamine, Depen, Depen Titratabs | ||||||||||||||||
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||||||||||||||||||
|
N/A |
3.2 hours |
3.2 hours |
||||||||||||||||
| CSA Schedule 1 View glossary of CSA terms | ||||||||||||||||||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
||||||||||||||||
| Pregnancy Category | ||||||||||||||||||
|
Category A
Studies show no risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
Category D
Positive evidence of risk
See the full pregnancy warnings document. |
||||||||||||||||
| Drug Interactions | ||||||||||||||||||
|
A total of 150 drugs are known to interact with Wilzin:
|
A total of 123 drugs are known to interact with Penicillamine:
|
A total of 123 drugs are known to interact with Cuprimine:
|
||||||||||||||||
| Alcohol/Food/Lifestyle Interactions | ||||||||||||||||||
|
|
|
||||||||||||||||
| Disease Interactions | ||||||||||||||||||
| First Approval Date | ||||||||||||||||||
|
N/A |
December 04, 1970 |
December 04, 1970 |
||||||||||||||||
| WADA Class View classifications | ||||||||||||||||||
|
N/A |
N/A |
N/A |
||||||||||||||||
| More Information | ||||||||||||||||||
| Patient Resources | ||||||||||||||||||
|
N/A |
||||||||||||||||||
| Professional Resources | ||||||||||||||||||
| Related Treatment Guide | ||||||||||||||||||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.